Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738517015 | Benzocaine and salicylamide only product in cutaneous dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3738518013 | Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Is a | Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Has active ingredient | Salicylamide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Has active ingredient | Benzocaine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Is a | Salicylamide + Benzocaine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel | Is a | True | Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR